Acorda Therapeutics, Inc.

DB:CDG Stock Report

Market Cap: €14.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Acorda Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CDG?
Owner TypeNumber of SharesOwnership Percentage
Private Companies80.000644%
Individual Insiders8,5520.689%
Institutions112,6539.07%
General Public1,120,88590.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.

Top Shareholders

Top 25 shareholders own 9.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.67%
Renaissance Technologies LLC
45,561€518.1k2.93%no data
2.75%
Acadian Asset Management LLC
34,131€388.1k0%no data
0.64%
The Vanguard Group, Inc.
7,988€90.8k0%no data
0.6%
Ron Cohen
7,488€85.2k0%no data
0.55%
BlackRock, Inc.
6,776€77.1k0.06%no data
0.53%
Telemetry Investments, L.L.C.
6,625€75.3k0%0.25%
0.31%
Bridgeway Capital Management, LLC
3,835€43.6k0%no data
0.3%
Wells Fargo & Company, Securities and Brokerage Investments
3,731€42.4k0.05%no data
0.14%
Deutsche Bank Aktiengesellschaft, London
1,700€19.3k0%no data
0.1%
Morgan Stanley & Co. International Plc Investment Account
1,274€14.5k167%no data
0.043%
Lauren Sabella
536€6.1k0%no data
0.041%
Kerry Clem
504€5.7k0%no data
0.041%
Royal Bank of Canada, Banking & Securities Investments
503€5.7k16,700%no data
0.024%
Russell Investment Management, LLC
300€3.4k0%no data
0.016%
Group One Trading LP, Asset Management Arm
204€2.3k-37.6%no data
0.002%
Ayalon Mutual Funds Ltd.
25€283.90%no data
0.0019%
Sandra Panem
24€272.60%no data
0.001%
RBC Dominion Securities Inc., Asset Management Arm
13€148.38.33%no data
0.00072%
Wells Fargo & Company, Private Banking and Investment Banking Arm
9€101.712.5%no data
0.00064%
Tower Research Capital LLC
8€90.4-98.7%no data
0.00024%
First Manhattan Co. LLC
3€33.950%no data
0.00016%
Eaton Vance Management
2€22.60%no data
0.00008%
Osaic Wealth, Inc. , Asset Management Arm
1€11.30%no data
0.00008%
Strategic Advisers LLC
1€11.30%no data
0.00008%
JPMorgan Chase & Co, Brokerage and Securities Investments
1€11.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/02 03:06
End of Day Share Price 2023/06/05 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Acorda Therapeutics, Inc. is covered by 28 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LeBoyerAegis Capital Corporation
Christopher RaymondBaird
John NewmanCanaccord Genuity